Search
Search Results
-
Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies
Type 2 diabetes (T2D) is a progressive disease, with many individuals eventually requiring basal insulin therapy to maintain glycaemic control....
-
Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
BackgroundThere are insufficient data on continuous glucose monitoring (CGM) in nonintensive insulin therapy patients. Using CGM and the recommended...
-
Use of diabetes technology in children
Children with type 1 diabetes and their caregivers face numerous challenges navigating the unpredictability of this complex disease. Although the...
-
Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis
Aims/hypothesisThe aim of this study was to determine the mechanism(s) for hypoglycaemia occurring late following oral glucose loading in patients...
-
Insulin: evolution of insulin formulations and their application in clinical practice over 100 years
The first preparation of insulin extracted from a pancreas and made suitable for use in humans after purification was achieved 100 years ago in...
-
Knowledge, safety, and impact of alcohol consumption in young adults with type 1 diabetes mellitus: a qualitative study
PurposeTo explore the lived experiences of alcohol consumption among young adults with type 1 diabetes.
MethodsFourteen semi-structured interviews...
-
A Podcast on the Use of CGM in Optimizing Type 2 Diabetes Management with Non-intensive Insulin Treatment in the Primary Care Setting
IntroductionType 2 diabetes is a widespread health concern with significant implications for patient well-being. Poor glycaemic control can lead to...
-
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
Aims/hypothesisA head-to-head randomised trial was conducted to evaluate hypoglycaemia safety with insulin degludec 200 U/ml (degludec U200) and...
-
Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review
Hybrid closed loop (HCL) systems are the combination of a pump for insulin delivery and a glucose sensor for continuous glucose monitoring. These...
-
Evaluation of Cardiovascular Risk in People with Type 1 Diabetes: A Comprehensive and Specific Proposed Practical Approach
People living with type 1 diabetes (T1D) have an increased risk of cardiovascular disease (CVD), and it is the leading cause of morbidity and...
-
Heterogeneity of glycaemic phenotypes in type 1 diabetes
Aims/hypothesisOur study aims to uncover glycaemic phenotype heterogeneity in type 1 diabetes.
MethodsIn the Study of the French-speaking Society of...
-
-
Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study
IntroductionThis study investigated glycaemic control in individuals with type 1 (T1D) or type 2 diabetes (T2D) 6 months after initiating fast-acting...
